The Efficacy and Safety of Gabapentinoids in Total Joint Arthroplasty: Systematic Review and Direct Meta-Analysis.
Charles P Hannon, Yale A Fillingham, James A Browne...
https://pubmed.ncbi.nlm.nih.gov/32586656/Actively Recruiting
Led by Thammasat University Hospital · Updated on 2026-08-07
80
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to compare the effectiveness of two pain relief drugs, mirogabalin and pregabalin, after unilateral primary total knee arthroplasty TKA in adults aged 50 to 85 years. The study evaluates which drug better reduces pain and improves function following knee replacement surgery. It is a randomized controlled trial conducted by Thammasat University Hospital. After surgery, participants are randomly assigned to receive either mirogabalin or pregabalin alongside standard medications. Those in the mirogabalin group take 5 mg tablets twice a day after breakfast and dinner for two weeks. Participants in the pregabalin group take 75 mg tablets once daily before bedtime for two weeks. During the study, participants pain scores will be measured frequently, starting every six hours for two days, then twice daily for two weeks, and weekly up to 12 weeks after surgery. Researchers will also monitor morphine use, knee movement range, knee function scores, sedation levels, incidence of sleepiness and dizziness, and hospital stay length. The total participation lasts up to 12 weeks post-surgery, with regular assessments to track recovery and safety.
CONDITIONS
Comparing Efficiency of Mirogabalin and Pregabalin in Primary TKA
Y
Yot Tanariyakul, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Thammasat University Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
,
Duration - 2 weeks
Participants receive either mirogabalin twice daily after meals or pregabalin once daily before bedtime for 2 weeks following knee surgery.
Daily medication intake with regular assessments
Duration - Up to 12 weeks
Participants are monitored for pain levels, knee function, medication use, and side effects up to 12 weeks after surgery.
Frequent pain score assessments initially, then weekly visits
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Charles P Hannon, Yale A Fillingham, James A Browne...
https://pubmed.ncbi.nlm.nih.gov/32586656/Jae-Yeon Kim, Salahadin Abdi, Billy Huh...
https://pubmed.ncbi.nlm.nih.gov/33380563/Thammasat University Hospital
Lead Sponsor